# Elevance Health vs GSK: valuation, size and margins compared

URL: https://funkfolio.com/compare/elv-vs-gsk

> Elevance Health ($93.8B, P/E 18.9) and GSK ($98.7B, P/E 17.6) compared: size, valuation, margins, debt, cash and price change.

---

## Elevance Health vs GSK

Elevance Health (ELV), health care, and GSK (GSK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

GSK is worth $98.7B on the stock market and Elevance Health $93.8B: GSK is valued at 5% more. Elevance Health trades at 18.9 times earnings and GSK at 17.6; operating margins in their latest fiscal years were 3.62% and 24.3%. Over the past year Elevance Health's share price has moved +37.5% and GSK's +6.42%.

### Key facts

- **Elevance Health market value:** $93.8B
- **GSK market value:** $98.7B
- **Elevance Health P/E:** 18.9
- **GSK P/E:** 17.6
- **Elevance Health revenue:** $199.1B FY to 2025-12-31
- **GSK revenue:** $43.4B FY to 2025-12-31
- **Superinvestors holding both:** 3

Market values as of 18 Nov 2026, 04:26 UTC.

Elevance Health vs GSK: every measure side by side

| Measure | Elevance Health | GSK |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United Kingdom |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $93.8B lower | $98.7B higher |
| Revenue | $199.1B higher | $43.4B lower |
| Earnings | $5.7B lower | $7.6B higher |
| Employees | 96,129 higher | 66,841 lower |
| Total assets | $121.5B higher | $81.1B lower |
| Valuation |  |  |
| P/E | 18.9 higher | 17.6 lower |
| P/S | 0.5 lower | 2.3 higher |
| P/B | 2.1 | — |
| Dividend yield | 1.54% | — |
| Profitability |  |  |
| Operating margin | 3.62% lower | 24.3% higher |
| Balance sheet |  |  |
| Net assets | $43.9B higher | $21.7B lower |
| Total liabilities | $77.5B higher | $59.9B lower |
| Total debt | $32B higher | $19.2B lower |
| Cash on hand | $9.5B higher | $4.5B lower |
| Price change |  |  |
| Today | -2.77% lower | -2.32% higher |
| 1 year | +37.5% higher | +6.42% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Elevance Health 131.1, GSK 103.6.

- Elevance Health (ELV)
- GSK (GSK)

Elevance Health and GSK share prices over one year, rebased to 100: Elevance Health ends at 131.1, GSK at 103.6.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | ELV | GSK |
| --- | --- | --- |
| Nov 28, 2025 | 102.2 | 100.7 |
| Dec 31, 2025 | 105.9 | 103.2 |
| Jan 30, 2026 | 104.5 | 108.6 |
| Feb 27, 2026 | 96.7 | 124.4 |
| Mar 31, 2026 | 88.5 | 116.1 |
| Apr 30, 2026 | 113.8 | 110.1 |
| May 29, 2026 | 118.8 | 106.3 |
| Jun 30, 2026 | 116.9 | 110.3 |
| Jul 31, 2026 | 113.6 | 108.8 |
| Aug 31, 2026 | 118.6 | 105.7 |
| Sep 30, 2026 | 117.5 | 101.3 |
| Oct 30, 2026 | 126.9 | 104.2 |
| Nov 17, 2026 | 131.1 | 103.6 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (3)

- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 1.4% / 0.4%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.3% / &lt;0.1%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.2% / 0.3%

#### Elevance Health only (16)

- [Seth Klarman](https://funkfolio.com/gurus/seth-klarman) 9.8%
- [Sequoia Fund team](https://funkfolio.com/gurus/sequoia-fund) 6.2%
- [Glenn Greenberg](https://funkfolio.com/gurus/glenn-greenberg) 5.2%
- [Matthew McLennan](https://funkfolio.com/gurus/first-eagle) 2.6%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) 2.5%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 2.2%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 2.0%
- [C.T. Fitzpatrick](https://funkfolio.com/gurus/ct-fitzpatrick) 1.7%
- [Stephen Yacktman](https://funkfolio.com/gurus/stephen-yacktman) 1.6%
- [Anthony Bozza](https://funkfolio.com/gurus/anthony-bozza) 1.2%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 0.9%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 0.5%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.4%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.2%

#### GSK only (8)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.1%
- [Thomas Kahn](https://funkfolio.com/gurus/thomas-kahn) 0.9%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.8%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.5%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.5%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 0.1%
- [Murray Stahl](https://funkfolio.com/gurus/murray-stahl) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Elevance Health / GSK). [Who owns ELV](https://funkfolio.com/stock/ELV/superinvestors) · [Who owns GSK](https://funkfolio.com/stock/GSK/superinvestors)

### More on Elevance Health

- [Elevance Health (ELV) stock page](https://funkfolio.com/stock/ELV)
- [Elevance Health market cap](https://funkfolio.com/stock/ELV/market-cap)
- [Elevance Health revenue](https://funkfolio.com/stock/ELV/revenue)
- [Elevance Health P/E ratio](https://funkfolio.com/stock/ELV/pe-ratio)
- [Elevance Health operating margin](https://funkfolio.com/stock/ELV/operating-margin)
- [Elevance Health total debt](https://funkfolio.com/stock/ELV/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on GSK

- [GSK (GSK) stock page](https://funkfolio.com/stock/GSK)
- [GSK market cap](https://funkfolio.com/stock/GSK/market-cap)
- [GSK revenue](https://funkfolio.com/stock/GSK/revenue)
- [GSK P/E ratio](https://funkfolio.com/stock/GSK/pe-ratio)
- [GSK operating margin](https://funkfolio.com/stock/GSK/operating-margin)
- [GSK total debt](https://funkfolio.com/stock/GSK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Elevance Health against its closest peers

- [Elevance Health vs Regeneron Pharmaceuticals](https://funkfolio.com/compare/elv-vs-regn)
- [Elevance Health vs Cigna Group](https://funkfolio.com/compare/ci-vs-elv)
- [Elevance Health vs HCA Healthcare](https://funkfolio.com/compare/elv-vs-hca)

#### GSK against its closest peers

- [GSK vs HCA Healthcare](https://funkfolio.com/compare/gsk-vs-hca)
- [GSK vs CVS Health](https://funkfolio.com/compare/cvs-vs-gsk)
- [GSK vs Moderna](https://funkfolio.com/compare/gsk-vs-mrna)
- [GSK vs Regeneron Pharmaceuticals](https://funkfolio.com/compare/gsk-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Elevance Health or GSK?**

By market value, GSK is the larger: $98.7B against $93.8B for Elevance Health. By revenue in its latest fiscal year, Elevance Health is the larger: $199.1B against $43.4B for GSK.

**Which has the higher P/E ratio?**

Elevance Health: 18.9, against 17.6 for GSK. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

GSK: 24.3%, against 3.62% for Elevance Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Elevance Health: $32B, against $19.2B for GSK. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Elevance Health and GSK?**

In their latest 13F filings, Jeremy Grantham (co-founder), Richard Pzena and Tweedy, Browne team hold both.

### Cite this page

Funkfolio, “Elevance Health vs GSK”, data as of 18 November 2026. https://funkfolio.com/compare/elv-vs-gsk

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
